Lipid profiling as an effective approach for identifying biomarkers/adverse events associated with pediatric anesthesia
Published by Elsevier Inc..
Adverse effects related to central nervous system (CNS) function in pediatric populations may, at times, be difficult, if not impossible to evaluate. Prolonged anesthetic exposure affects brain excitability and anesthesia during the most sensitive developmental stages and has been associated with mitochondrial dysfunction, aberrant lipid metabolism and synaptogenesis, subsequent neuronal damage, as well as long-term behavioral deficits. There has been limited research evaluating whether and how anesthetic agents affect cellular lipids, the most abundant components of the brain other than water. Therefore, this review discusses: (1) whether the observed anesthetic-induced changes in lipid profiles seen in preclinical studies represents early signs of neurotoxicity; (2) the potential mechanisms underlying anesthetic-induced brain injury; and (3) whether lipid biomarker(s) identified in preclinical studies can serve as markers for the early clinical detection of anesthetic-induced neurotoxicity.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:354 |
|---|---|
| Enthalten in: |
Toxicology and applied pharmacology - 354(2018) vom: 01. Sept., Seite 191-195 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wang, Cheng [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anesthetic-induced |
|---|
| Anmerkungen: |
Date Completed 28.01.2019 Date Revised 28.01.2019 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.taap.2018.03.017 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM282064508 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM282064508 | ||
| 003 | DE-627 | ||
| 005 | 20231225033053.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.taap.2018.03.017 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0940.xml |
| 035 | |a (DE-627)NLM282064508 | ||
| 035 | |a (NLM)29550513 | ||
| 035 | |a (PII)S0041-008X(18)30101-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wang, Cheng |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Lipid profiling as an effective approach for identifying biomarkers/adverse events associated with pediatric anesthesia |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.01.2019 | ||
| 500 | |a Date Revised 28.01.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Published by Elsevier Inc. | ||
| 520 | |a Adverse effects related to central nervous system (CNS) function in pediatric populations may, at times, be difficult, if not impossible to evaluate. Prolonged anesthetic exposure affects brain excitability and anesthesia during the most sensitive developmental stages and has been associated with mitochondrial dysfunction, aberrant lipid metabolism and synaptogenesis, subsequent neuronal damage, as well as long-term behavioral deficits. There has been limited research evaluating whether and how anesthetic agents affect cellular lipids, the most abundant components of the brain other than water. Therefore, this review discusses: (1) whether the observed anesthetic-induced changes in lipid profiles seen in preclinical studies represents early signs of neurotoxicity; (2) the potential mechanisms underlying anesthetic-induced brain injury; and (3) whether lipid biomarker(s) identified in preclinical studies can serve as markers for the early clinical detection of anesthetic-induced neurotoxicity | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Anesthetic-induced | |
| 650 | 4 | |a Biomarker | |
| 650 | 4 | |a Development | |
| 650 | 4 | |a Lipidomics | |
| 650 | 4 | |a Neurotoxicity | |
| 650 | 7 | |a Anesthetics |2 NLM | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a Lipids |2 NLM | |
| 700 | 1 | |a Han, Xianlin |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Fang |e verfasserin |4 aut | |
| 700 | 1 | |a Patterson, Tucker A |e verfasserin |4 aut | |
| 700 | 1 | |a Hanig, Joseph P |e verfasserin |4 aut | |
| 700 | 1 | |a Paule, Merle G |e verfasserin |4 aut | |
| 700 | 1 | |a Slikker, William |c Jr |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Toxicology and applied pharmacology |d 1959 |g 354(2018) vom: 01. Sept., Seite 191-195 |w (DE-627)NLM000010979 |x 1096-0333 |7 nnns |
| 773 | 1 | 8 | |g volume:354 |g year:2018 |g day:01 |g month:09 |g pages:191-195 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.taap.2018.03.017 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 354 |j 2018 |b 01 |c 09 |h 191-195 | ||